Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Cours de formation | 2023
la douleur chronique, à propos des prescripteurs, les guides de pratique clinique
Training | 2023
Chronic pain, About prescribers, Clinical guidance
Guide or handbook | 2022
Safer supply, About prescribers, Hesitancy of prescribers
Report | 2023
2SLGBTQI+, Harm reduction, About PWUD
We examined acceptability of and preferences for potential medications for treating methamphetamine use disorder (MUD) among people who use methamphetamine and examined how benefits and drawbacks o
Original research | 2023
Stimulants, Safer supply, About PWUD
A scoping review was undertaken to examine the impact of methamphetamine use on medications for opioid use disorder [MOUD] retention.
Scoping review | 2023
Stimulants, About PWUD, Substitution/OAT, Transitions in care/treatment
We conducted a qualitative study evaluating one opioid treatment program's experience, including benefits and challenges with implementing a methadone van, to inform future policy and clinical prac
Original research | 2023
Barriers and enablers, Substitution/OAT, About prescribers, About PWUD
We discuss major domains of xylazine’s harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine’s public health and policy context.
Lit review | 2023
About prescribers, Illegal drugs, Harm reduction, Clinical guidance
The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT).
Lit review | 2023
Carries/take-home doses, Hesitancy of prescribers , Policy/Regulatory
Emerging literature suggests that healthcare workers also experience moral injury, particularly in the context of the ongoing COVID-19 pandemic.
Original research | 2023
About prescribers, Mental health, Workplace
Commentary | 2023
Overdose, Illegal drugs, Clinical guidance
In this study, we seek to evaluate the experiences of Black individuals with OUD in seeking treatment.
Original research | 2023
Equity, Substitution/OAT, Diversion, About PWUD
Commentary | 2023
Harm reduction, Digital health
Commentary | 2023
Policy/Regulatory, Decriminalization/legalization
Using the Province of British Columbia, Canada, as a case study, we undertook an evidence-based multi-criteria policy analysis of three models for defining personal possession: 1) a model that defi
Original research | 2023
Policy/Regulatory, Decriminalization/legalization
Notre objectif consistait à rendre compte des expériences, des problèmes et des recommandations des personnes consommant de la méthamphétamine et ayant eu recours à des services hospitaliers.
Recherche | 2023
les stimulants, les hôpitals, à propos des personnes qui utilisent des drogues, la réduction des méfaits
Our aim was to identify the experiences, issues and recommendations of people who use methamphetamine and have accessed hospital services.
Original research | 2023
Stimulants, Hospitals, About PWUD, Harm reduction
Report | 2023
About prescribers, Social services, Policy/Regulatory
The objective of this study was to develop a neural network model to identify fentanyl and related analogues more accurately in drug samples compared to traditional analysis by technicians.
Original research | 2023
Drug checking, Illegal drugs
